Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS 41004 in Psoriasis Plaque Test
NCT01283698Phase 2Completed
- Sponsor
- Almirall
- Start
- Jan 2011
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene, betamethasone dipropionate in plaque psoriasis, sponsored by Almirall. Started Jan 2011; status: completed.
02
Drugs
bexarotenebetamethasone dipropionate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01283698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283698.